Owens & Minor (OMI) Projected to Post Quarterly Earnings on Friday

Owens & Minor (NYSE:OMI) will likely be posting its quarterly earnings results before the market opens on Friday, February 28th. Analysts expect Owens & Minor to post earnings of $0.53 per share and revenue of $2.68 billion for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Owens & Minor Stock Up 10.7 %

Shares of NYSE OMI opened at $7.08 on Wednesday. The firm has a market cap of $545.55 million, a price-to-earnings ratio of -10.88, a PEG ratio of 0.20 and a beta of 0.48. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. Owens & Minor has a 52-week low of $6.07 and a 52-week high of $28.35. The business’s 50 day moving average is $11.79 and its two-hundred day moving average is $13.39.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Barclays cut their target price on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. Citigroup dropped their price target on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research note on Tuesday, November 5th. Robert W. Baird dropped their price target on shares of Owens & Minor from $14.00 to $10.00 and set a “neutral” rating for the company in a research note on Tuesday. Finally, UBS Group dropped their price target on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $16.21.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.